BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21876856)

  • 1. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.
    Renfrew PD; Quan H; Doig CJ; Dixon E; Molinari M
    Can J Gastroenterol; 2011 Jul; 25(7):359-64. PubMed ID: 21876856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
    Molinari M; Renfrew PD; Petrie NM; De Coutere S; Abdolell M
    Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
    Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
    PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
    Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
    Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
    Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate.
    Myers RP; Shaheen AA; Aspinall AI; Quinn RR; Burak KW
    J Hepatol; 2011 Mar; 54(3):462-70. PubMed ID: 21109324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada.
    Burak KW; Meeberg GA; Myers RP; Fick GH; Swain MG; Bain VG; Kneteman NM; Hilsden RJ
    Can J Gastroenterol Hepatol; 2016; 2016():1329532. PubMed ID: 27446823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
    Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
    JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.
    Kalra A; Wedd JP; Bambha KM; Gralla J; Golden-Mason L; Collins C; Rosen HR; Biggins SW
    Liver Transpl; 2017 Feb; 23(2):155-165. PubMed ID: 28006875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.